Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Change in Acquisitions & Divestments (2022 - 2025)

Agilon Health (AGL) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $33.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 16.83% year-over-year to $33.3 million, compared with a TTM value of $193.9 million through Dec 2025, down 6.3%, and an annual FY2025 reading of $193.9 million, down 6.3% over the prior year.
  • Change in Acquisitions & Divestments was $33.3 million for Q4 2025 at Agilon Health, down from $35.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $90.0 million in Q2 2025 and bottomed at $683000.0 in Q1 2022.
  • Average Change in Acquisitions & Divestments over 4 years is $38.6 million, with a median of $36.0 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments surged 4078.62% in 2023, then tumbled 52.62% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $37.4 million in 2022, then dropped by 19.44% to $30.1 million in 2023, then soared by 32.98% to $40.1 million in 2024, then dropped by 16.83% to $33.3 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for AGL at $33.3 million in Q4 2025, $35.2 million in Q3 2025, and $90.0 million in Q2 2025.